Why radiopharmaceuticals are gaining ground in the fight against cancer
Drug Target Review
JUNE 6, 2025
In an interview with our team, Delpassand shared his perspective on how targeted radiopharmaceuticals are reshaping cancer treatment and what lies ahead for this evolving field. Prior treatments and patient histories often introduce variables that can affect outcomes, making thoughtful trial design essential for generating reliable data.
Let's personalize your content